These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7256798)

  • 1. The dynamics of clindamycin-2-phosphate in vivo and its transfer to tissues.
    Imoto T; Takasaki K; Miyachi S; Sasaki J
    Tokai J Exp Clin Med; 1981 Jan; 6(1):85-95. PubMed ID: 7256798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on antimicrobial concentration of clindamycin phosphate in serum, pelvic dead space exudate, and pelvic organs/tissues].
    Obata T; Sasaki J; Takahashi K; Eguchi M; Yamamoto Y; Deguchi K; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1986 Feb; 39(2):317-25. PubMed ID: 3712747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of concentrations of clindamycin phosphate in bone marrow blood and tissue].
    Nakamura N; Ogata H; Fukushima M; Umeda T; Deguchi K; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1986 Jan; 39(1):133-40. PubMed ID: 3702055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentrations of clindamycin phosphate in lung tissues].
    Ikeda T; Sakai T; Kikuchi K; Suito T
    Jpn J Antibiot; 1985 Dec; 38(12):3477-80. PubMed ID: 3834131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ophthalmic use of clindamycin-2-phosphate (author's transl)].
    Oishi M; Nishizuka K; Motoyama M; Ogawa T
    Jpn J Antibiot; 1977 Jan; 30(1):100-6. PubMed ID: 300120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fundamental and clinical investigation of clindamycin-2-phosphate in otorhinolaryngological field (author's transl)].
    Sambe B; Murakami H; Kobayashi K; Jyo K; Inafuku M
    Jpn J Antibiot; 1977 Jan; 30(1):94-9. PubMed ID: 264983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clindamycin-2-phosphate in the treatment of respiratory infections and its distribution into pleural effusion].
    Takamoto M; Harada S; Harada Y; Kitahara Y; Kawahara M; Ishibashi T; Shinoda A
    Jpn J Antibiot; 1987 Apr; 40(4):727-34. PubMed ID: 3613089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preclinical and clinical studies of clindamycin-2-phosphate (author's transl)].
    Sawae Y; Takii M
    Jpn J Antibiot; 1977 Jan; 30(1):42-50. PubMed ID: 839643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.
    Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG
    Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of therapeutic levels of intravitreally injected liposome-encapsulated clindamycin in the rabbit.
    Fiscella R; Peyman GA; Fishman PH
    Can J Ophthalmol; 1987 Oct; 22(6):307-9. PubMed ID: 3427538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of clindamycin-2-phosphate in ophthalmology (author's transl)].
    Tokuda H; Hatano H; Kayaba T
    Jpn J Antibiot; 1977 Jan; 30(1):107-10. PubMed ID: 14269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration into bone and tissues of clindamycin phosphate.
    Baird P; Hughes S; Sullivan M; Willmot I
    Postgrad Med J; 1978 Feb; 54(628):65-7. PubMed ID: 634877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The fundamental and clinical studies on clindamycin-2-phosphate in the otorhinolaryngologic field (author's transl)].
    Iwasawa T
    Jpn J Antibiot; 1977 Jan; 30(1):82-93. PubMed ID: 264982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clindamycin phosphate kinetics in subjects undergoing CAPD.
    Schwartz MT; Kowalsky SF; McCormick EM; Parker MA; Echols RM
    Clin Nephrol; 1986 Dec; 26(6):303-6. PubMed ID: 3802597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic and clinical studies on clindamycin for intravenous injection (author's transl)].
    Imaoka M; Uzuka Y; Noguchi Y; Watanabe K; Matsumoto K
    Jpn J Antibiot; 1977 Jan; 30(1):51-8. PubMed ID: 839644
    [No Abstract]   [Full Text] [Related]  

  • 16. An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations.
    Levinson RS; Mitan SJ; Steinmetz JI; Gattermeir DJ; Schumacher RJ; Joffrion JL
    Clin Ther; 2005 Dec; 27(12):1894-900. PubMed ID: 16507375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clindamycin-2-phosphate and surgical infections (author's transl)].
    Ishibiki H; Murayama N; Hosoda Y; Katsumoto K; Takami H
    Jpn J Antibiot; 1977 Jan; 30(1):69-75. PubMed ID: 320362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized inhibition of clindamycin-2-phosphate hydrolysis due to product inhibition by inorganic phosphate.
    Blenkharn JI; Darrell JH
    J Antimicrob Chemother; 1981 Jan; 7(1):101-4. PubMed ID: 7204287
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of lincomycin and clindamycin phosphate in a canine model.
    Brown RB; Barza M; Brusch JL; Hashimoto Y; Weinstein L
    J Infect Dis; 1975 Mar; 131(3):252-60. PubMed ID: 1127255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral development of clindamycin-2-phosphate.
    Riebe KW; Oesterling TO
    Bull Parenter Drug Assoc; 1972; 26(3):139-46. PubMed ID: 5035118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.